BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 4039567)

  • 1. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of renal clearance of cisplatin (cis-dichlorodiammine platinum ii) and its modification by furosemide and probenecid.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1982 Jul; 31(13):2243-6. PubMed ID: 6889863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the protective effect of chloride salts on cisplatin nephrotoxicity.
    Daley-Yates PT; McBrien DC
    Biochem Pharmacol; 1985 Jul; 34(13):2363-9. PubMed ID: 4040367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin nephrotoxicity: role of filtration and tubular transport of cisplatin in isolated perfused kidneys.
    Miura K; Goldstein RS; Pasino DA; Hook JB
    Toxicology; 1987 May; 44(2):147-58. PubMed ID: 3564050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
    Siddik ZH; Newell DR; Boxall FE; Harrap KR
    Biochem Pharmacol; 1987 Jun; 36(12):1925-32. PubMed ID: 3297068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.
    Dumas M; de Gislain C; d'Athis P; Chadoint-Noudeau V; Escousse A; Guerrin J; Autissier N
    Cancer Chemother Pharmacol; 1989; 23(1):37-40. PubMed ID: 2909288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue injury and repair in the rat kidney after exposure to cisplatin or carboplatin.
    Nonclercq D; Toubeau G; Laurent G; Tulkens PM; Heuson-Stiennon JA
    Exp Mol Pathol; 1989 Oct; 51(2):123-40. PubMed ID: 2680578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
    Jones MM; Basinger MA; Beaty JA; Holscher MA
    Cancer Chemother Pharmacol; 1991; 29(1):29-32. PubMed ID: 1742846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative nephrotoxicity of a novel platinum compound, cisplatin, and carboplatin in male Wistar rats.
    Wolfgang GH; Dominick MA; Walsh KM; Hoeschele JD; Pegg DG
    Fundam Appl Toxicol; 1994 Jan; 22(1):73-9. PubMed ID: 8125216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
    Uozumi J; Litterst CL
    Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platinum agent-induced nephrotoxicity via organic cation transport system].
    Yonezawa A
    Yakugaku Zasshi; 2012; 132(11):1281-5. PubMed ID: 23123720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
    Bird JE; Walser MM; Quebbemann AJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minireview. The nephrotoxicity of cisplatin.
    Goldstein RS; Mayor GH
    Life Sci; 1983 Feb; 32(7):685-90. PubMed ID: 6338333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity: insights into mechanism.
    Safirstein R; Winston J; Moel D; Dikman S; Guttenplan J
    Int J Androl; 1987 Feb; 10(1):325-46. PubMed ID: 3583421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular metabolites of cisplatin in the rat kidney.
    Mistry P; Lee C; McBrien DC
    Cancer Chemother Pharmacol; 1989; 24(2):73-9. PubMed ID: 2731314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collecting duct function in cis-platinum nephrotoxicity.
    Wilson DR; Honrath U
    Can J Physiol Pharmacol; 1987 Jun; 65(6):1200-4. PubMed ID: 3621067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and metabolism of cisplatin by rat kidney.
    Safirstein R; Miller P; Guttenplan JB
    Kidney Int; 1984 May; 25(5):753-8. PubMed ID: 6540826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective action of glycine in cisplatin nephrotoxicity.
    Heyman SN; Rosen S; Silva P; Spokes K; Egorin MJ; Epstein FH
    Kidney Int; 1991 Aug; 40(2):273-9. PubMed ID: 1942775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.